Filing Details
- Accession Number:
- 0001209191-23-057117
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-01 19:42:56
- Reporting Period:
- 2023-11-30
- Accepted Time:
- 2023-12-01 19:42:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1697532 | Applied Therapeutics Inc. | APLT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1775490 | Shoshana Shendelman | C/O Applied Therapeutics, Inc. 545 Fifth Avenue, Suite 1400 New York NY 10017 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-11-30 | 3,968 | $1.97 | 2,596,387 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,750,000 | Indirect | See footnote |
Common Stock | 1,492,094 | Indirect | See footnote |
Common Stock | 709,720 | Indirect | See footnote |
Common Stock | 290,280 | Indirect | See footnote |
Common Stock | 88,397 | Indirect | See footnote |
Footnotes
- The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
- Through a grantor retained annuity trust.
- Through a family trust controlled by the reporting person's spouse.
- Through the reporting person's spouse.
- Through a family trust controlled by the reporting person.
- Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.